Japanese Healthcare Services Stock News

TSE:4523
TSE:4523Pharmaceuticals

Does Real‑World Leqembi Iqlik Data And At‑Home Use Shift The Bull Case For Eisai (TSE:4523)?

Eisai and Biogen recently reported real-world data from the three-year LEADER study showing that nearly 83% of early Alzheimer’s patients on Leqembi remained stable or improved over about 17 months, and secured U.S. FDA approval for once-weekly subcutaneous Leqembi Iqlik as an at-home initiation option. These updates suggest that Leqembi’s convenience, persistence on therapy and consistency across diverse patient groups could be increasingly important drivers of its clinical and commercial...
TSE:2175
TSE:2175Professional Services

SMS (TSE:2175) Could Be 48% Undervalued As Valuation Signals Split

SMS stock: recent performance and business context SMS (TSE:2175) has drawn attention after a strong run recently, with the stock up about 20% over the past month and roughly 37% in the past 3 months, prompting fresh interest in its underlying business. The company focuses on information infrastructure for Japan’s aging society, with revenue of ¥64,735 and a reported loss of ¥14,317. This means investors are weighing solid annual revenue growth against ongoing profitability challenges. See...
TSE:2337
TSE:2337Real Estate

Ichigo (TSE:2337) Held Its Q1 2027 Earnings Call, Is The Stock A Bargain?

Ichigo Q1 2027 earnings call as a fresh catalyst Ichigo (TSE:2337) recently released its Q1 2027 pre recorded earnings call on July 15, 2026, giving investors fresh information on its real estate, hotel, and clean energy businesses in Japan. See our latest analysis for Ichigo. Ichigo's Q1 2027 earnings update comes after a mixed share price pattern, with the stock up 4.11% over the last day but down 15.98% over 90 days. Meanwhile, 1 year and 3 year total shareholder returns of 17.47% and...
TSE:4507
TSE:4507Pharmaceuticals

Shionogi (TSE:4507) Looks Cheap After FDA Accepts Cefiderocol Pediatric sNDA

Why the FDA sNDA for cefiderocol matters for Shionogi stock The FDA sNDA acceptance for Shionogi (TSE:4507) antibiotic cefiderocol in pediatric hospital and urinary infections highlights a fresh regulatory milestone that could influence how investors think about the company s long term revenue mix. See our latest analysis for Shionogi. Investors have seen Shionogi s share price gain 3.45% over the past month, even after a roughly 10.49% decline over 90 days. At the same time, the 1 year total...
TSE:9064
TSE:9064Logistics

How Yamato’s New Corporate Value Enhancement Committee Will Impact Yamato Holdings (TSE:9064) Investors

In July 2026, Yamato Holdings Co., Ltd. established a "Corporate Value Enhancement Committee," a six-member advisory body under the Board composed mainly of outside directors and chaired by President Toshiyuki Sakurai to focus on maximizing corporate value. This new committee, sitting alongside Yamato’s existing nomination, compensation, compliance, and risk bodies, signals a reinforced governance framework centered on independent oversight of long-term value creation. We will now explore...
TSE:7459
TSE:7459Healthcare

Is MediPal Holdings (TSE:7459) Still Worth A Look On Higher Dividend Guidance?

MediPal Holdings (TSE:7459) has updated investors with higher full year dividend guidance and revised earnings expectations after completing its tender offer for PALTAC Corporation, which shifts more of PALTAC's profit fully onto its books. See our latest analysis for MediPal Holdings. Recent moves suggest growing interest in MediPal Holdings, with a 1 month share price return of 9.92% and a 1 year total shareholder return of 19.90%. This points to building momentum around the revised...
TSE:3391
TSE:3391Consumer Retailing

Why Tsuruha Holdings’ (TSE:3391) Soaring Sales With Lower EPS May Redefine Its Investment Story

Tsuruha Holdings Inc. previously reported first-quarter 2026 results, with sales rising to ¥636,886 million from ¥272,530 million and net income increasing to ¥13,477 million from ¥11,112 million a year earlier. Despite higher sales and net income, basic earnings per share from continuing operations fell to ¥29.75 from ¥45.66, hinting at changes in share count or profit mix that matter for investors. Next, we examine how this mix of rapid sales expansion and lower earnings per share shapes...
TSE:6367
TSE:6367Building

Carrier Stock And 2 Cooling Shares Tied To Europe’s Heat Wave Spending

Europe’s record heat is turning air conditioning from a luxury into critical infrastructure, and that shift is starting to influence where capital flows. As governments debate funding for cooling in hospitals and schools and push for greener, more efficient systems, some stocks exposed to this climate adaptation story could see fresh attention while others may face tougher questions. This article explores how the news-driven theme around European air conditioning expansion connects to three...
TSE:8273
TSE:8273Multiline Retail

Izumi (TSE:8273) Posted Strong Q1 Growth, Is The Valuation Gap Still Justified?

Izumi Q1 earnings put recent performance in focus Izumi (TSE:8273) has drawn investor attention after reporting first quarter results to May 31, 2026, with sales of ¥125,235 million and net income of ¥4,528 million, both higher than a year earlier. See our latest analysis for Izumi. Izumi's share price has risen around 6% over the past month, while the 1 year total shareholder return is close to flat and the 3 and 5 year total shareholder returns remain mildly negative, suggesting only modest...
TSE:4523
TSE:4523Pharmaceuticals

Eisai (TSE:4523) Following Leqembi Home Dosing Approval Is The Alzheimer’s Upside Already Priced In

Eisai (TSE:4523) is back in focus after fresh Alzheimer’s data and a new at-home dosing option for Leqembi. These developments together reshape how investors might think about the company’s neurology franchise. See our latest analysis for Eisai. Eisai’s latest Alzheimer’s updates arrive alongside a 12.12% 1 month share price return, though the share price is still down 7.04% year to date, while the 1 year total shareholder return of 16.39% contrasts with weaker 3 and 5 year total shareholder...
TSE:9501
TSE:9501Electric Utilities

Tokyo Electric Power Company Holdings (TSE:9501) Looks Cheap As IAEA Backs Fukushima Water Safety

The International Atomic Energy Agency has again verified that ALPS treated water discharged from Fukushima by Tokyo Electric Power Company Holdings (TSE:9501) complies with Japan’s tritium limits and international safety standards, keeping regulatory scrutiny firmly in focus. See our latest analysis for Tokyo Electric Power Company Holdings. While the latest IAEA confirmation reinforces confidence around Fukushima water management, Tokyo Electric Power Company Holdings’ share price tells a...
TSE:4324
TSE:4324Media

Is Dentsu (TSE:4324) Using South Asia Leadership Changes To Prove Its Transformation Narrative?

Dentsu Group has appointed Ajay Gupte as chief operating officer for South Asia, working alongside CEO Harsha Razdan to drive transformation, efficiency and a more agile, collaborative network across the region. By bringing in a leader with deep experience in media, digital transformation and large-scale business change, Dentsu is explicitly tying its South Asia operational overhaul to its broader Business to Business to Society model and client-centric growth ambitions. We’ll now examine...
TSE:3349
TSE:3349Consumer Retailing

The Bull Case For COSMOS Pharmaceutical (TSE:3349) Could Change Following Dividend Shift And 2027 Guidance

COSMOS Pharmaceutical Corporation recently reported full-year results for the year ended May 31, 2026, with sales of ¥1,099,583 million, net income of ¥32,046 million, and basic earnings per share of ¥404.33, alongside an increased annual dividend of ¥44.50 per share for fiscal 2026. At the same time, the company outlined lower year-end dividend guidance of ¥42.00 per share and issued detailed earnings forecasts for fiscal 2027, giving investors clearer visibility into expected sales,...
TSE:5423
TSE:5423Metals and Mining

Tokyo Steel Manufacturing (TSE:5423) Stock Faces Margin Compression Narrative After 3.6% Net Profit Result

Tokyo Steel Manufacturing (TSE:5423) opened Q1 2027 with revenue of ¥72,927 million and basic EPS of ¥18.40, setting the tone for a period where trailing figures and recent quarters tell a mixed story on profitability. Over the last five reported quarters, revenue has moved between ¥60,032 million and ¥73,862 million while basic EPS has ranged from ¥8.19 to ¥47.11, giving investors a clear view of how earnings have tracked against a relatively tight revenue band. With trailing margins thinner...
TSE:9433
TSE:9433Wireless Telecom

Is KDDI (TSE:9433) Cheap Following Its BMW And Verizon 5G Telematics Deal?

Verizon Business and KDDI (TSE:9433) are working with BMW Group to supply 5G standalone telematics connectivity for newly manufactured BMW and MINI vehicles in the U.S., integrating KDDI’s Global Communications Platform with Verizon’s network. See our latest analysis for KDDI. The recent 5G telematics deal with BMW comes as KDDI’s share price shows firm positive momentum, with a 30-day share price return of 5.62% and a 1-year total shareholder return of 20.12%. The 5-year total shareholder...
TSE:6758
TSE:6758Consumer Durables

Sony’s Digital-Only PlayStation Shift Could Be A Game Changer For Sony Group (TSE:6758)

Sony Group recently announced it will end production of physical discs for all new PlayStation games from January 2028, shifting fully to digital downloads via the PlayStation Store and limiting access in 122 countries that lack digital support. This move highlights Sony’s push toward a fully digital gaming ecosystem, raising important questions about accessibility, resale value loss, and how players engage with its entertainment platform. We’ll now examine how Sony’s planned move to...
TSE:9064
TSE:9064Logistics

Yamato Holdings (TSE:9064) Forms A Corporate Value Committee, Is The Upside Already Priced In?

Why Yamato Holdings Stock Is Back on Governance Watchlists Yamato Holdings (TSE:9064) has put governance firmly in the spotlight after its board approved a new Corporate Value Enhancement Committee, a voluntary advisory body focused on maximizing corporate value. The committee, formed on July 16, 2026, sits alongside Yamato Holdings existing Nomination and Compensation Committee and Compliance and Risk Committee, giving investors another lens on how the board thinks about long term...
TSE:2502
TSE:2502Beverage

Is Asahi Group Holdings (TSE:2502) Undervalued Following 2026 Guidance And Dividend Update?

Asahi Group Holdings (TSE:2502) has come into focus after issuing consolidated earnings guidance for 2026 alongside updated year end dividend expectations, giving investors fresh detail on projected sales, profit and shareholder returns. See our latest analysis for Asahi Group Holdings. The latest guidance and dividend update come after a period where momentum in Asahi Group Holdings' share price has been mixed. A 5.77% 1 month share price return contrasts with a year to date share price...
TSE:7974
TSE:7974Entertainment

Nintendo (TSE:7974) Expands Zelda Licensing With Hasbro, Is The Stock Still Undervalued?

Hasbro’s new multi year licensing partnership with Nintendo (TSE:7974) around The Legend of Zelda, with products previewed at San Diego Comic Con 2026 and a 2027 rollout, is drawing fresh attention to Nintendo stock. See our latest analysis for Nintendo. Despite the Zelda licensing news lifting sentiment and a 1 day share price return of 3.02% to ¥7,294.0, Nintendo’s year to date share price return is down 31.51%, and its 1 year total shareholder return has declined 42.48%, even though the 5...
TSE:2433
TSE:2433Media

Hakuhodo DY Holdings (TSE:2433) Approved Restricted Stock Awards, Is The Valuation Fully Priced?

Hakuhodo DY Holdings (TSE:2433) drew investor attention after its board approved the disposal of 275,950 treasury shares as restricted stock compensation for directors and officers at ¥1,222 per share. See our latest analysis for Hakuhodo DY Holdings. The restricted stock plan lands at a time when Hakuhodo DY Holdings' short term momentum has been positive, with a 30 day share price return of 12.91% and a 90 day share price return of 16.38%. However, the 5 year total shareholder return is...
TSE:2871
TSE:2871Food

Is Nichirei (TSE:2871) Fully Valued Following Its Cyberattack Recovery?

Cyberattack recovery and bond shelf filing put Nichirei in focus Nichirei (TSE:2871) is back on investor radars after a cyberattack disrupted its temperature controlled logistics and frozen food operations, followed by an announcement of resumed shipping and a ¥50 billion bond shelf registration. See our latest analysis for Nichirei. The cyberattack and bond shelf filing come against a backdrop of firm share price momentum, with Nichirei’s 90 day share price return of 10.96% and 1 year total...